FDA inspection
Atomvie Global Radiopharma Inc.: FDA inspection ending Jul 19, 2019
FDA inspection 1100903 · No Action Indicated (NAI) · Hamilton
Key facts
| Inspection ID | 1100903 |
|---|---|
| Firm | Atomvie Global Radiopharma Inc. |
| FEI number | 3007998963 |
| Address | Nrb A316, 1-1280 Main St W |
| City | Hamilton |
| Country | Canada |
| Fiscal year | 2019 |
| Inspection end date | Jul 19, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data